Redburn Atlantic trimmed Visa’s price target from $310 to $300 but kept a Neutral rating, proving that sometimes, even ...

Microsoft continues to be Wall Street’s software sweetheart, with Legacy Capital Wealth Partners LLC upping their stake by ...

Chevron’s stock tiptoed up 0.8%, but before you celebrate with caviar, trading volume dropped a dramatic 70%—someone hit ...

Values Added Financial LLC increased its Apple stake by 6.5%, now holding 28,275 shares worth over $7 million. Apple is the ...

Renaissance Technologies dramatically ramped up its stake in Southern Copper by over 1,400% in Q4, acquiring nearly 408,000 ...

Barclays lowered Wells Fargo’s price target from $92.00 to $87.00, though it maintained an “overweight” rating, suggesting ...

NVIDIA’s rollercoaster continues as Rosenblatt Securities slashes its target price from $220 to $200, despite keeping a “buy” ...

Zacks Research just trimmed its FY2025 earnings forecast for AbbVie, shaving it from $12.14 to $12.02 per share. This modest ...

Advisors Capital Management gave Home Depot a hearty thumbs-up by upping its stake 5.6% last quarter, joining a crowd of ...

Thermo Fisher Scientific is flexing its biotech muscles in 2025, ranking third among the top healthcare stocks to watch. With ...

Walt Disney’s stock took a modest tumble after UBS Group lowered its price target from $130 to $105, despite keeping a “buy” ...

Zacks Investment Management trimmed its Merck holdings by 18.2%, offloading over 217,000 shares but still clinging to nearly ...